Research output per year
Research output per year
Fingerprint
Dive into the research topics where Institute for Next Generation Healthcare is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma
Immune Atlas Consortium, Jan 2026, In: Nature Cancer. 7, 1, p. 224-246 23 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression
Vieira dos Santos, J., Melnekoff, D. T., Aleman, A., Mouhieddine, T. H., Montes de Oca, R., Wang, F., Rajeeve, S., Bhalla, S., Van Oekelen, O., Upadhyaya, B., Ghodke-Puranik, Y., Leshchenko, V., Kim-Schulze, S., Rahman, A., Afik, S., Lewinsky, H., Plaks, V., Thibaud, S., Cho, H. J. & Richter, J. & 9 others, , 10 Feb 2026, In: Blood advances. 10, 3, p. 604-607 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
FaMMily Affairs: Dissecting inherited contributions to multiple myeloma risk
Bodnar, S., Brander, T., Gold, J., Iverson, A., Lagana, A., Onel, K., Jagannath, S., Parekh, S. & Thibaud, S., Feb 2025, In: Seminars in Hematology. 62, 1, p. 11-19 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Melanoma antigen genes (MAGE); novel functional targets in multiple myeloma
Mei, A. H. C., Laganà, A., Osman, R. & Cho, H. J., Feb 2025, In: Seminars in Hematology. 62, 1, p. 43-49 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy
Aleman, A., Van Oekelen, O., Melnekoff, D. T., Grossman, L., Mouhieddine, T. H., Kurowski, A., Odak, I., Reci, S., Desai, S., Meledathu, S., Naidu, M. P., Shukla, R. P., Dutta, R. P., Kappes, K., Serebryakova, K., Jackson, H., Lu, J., Chatikhine, A., Kulkarni, R. & Moinfar, Z. & 15 others, , 21 Aug 2025, In: New England Journal of Medicine. 393, 8, p. 823-825 3 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
The role of 1q abnormalities in multiple myeloma: Genomic insights, clinical implications, and therapeutic challenges
Avigan, Z. M., Mitsiades, C. S. & Laganà, A., Feb 2025, In: Seminars in Hematology. 62, 1, p. 20-30 11 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Utilizing RADAR for the Integration of Genomic Data and Immunotherapy Targets in Precision Oncology for Multiple Myeloma
Laganà, A., Sariya, S., Melnekoff, D. T., Ram, M. & Parekh, S., 21 Aug 2025, Cancer Detection and Diagnosis: A Handbook of Emerging Technologies. CRC Press, p. 280-294 15 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma
Van Oekelen, O., Amatangelo, M., Guo, M., Upadhyaya, B., Cribbs, A. P., Kelly, G., Patel, M., Kim-Schulze, S., Flynt, E., Lagana, A., Gooding, S., Merad, M., Jagganath, S., Pierceall, W. E., Oppermann, U., Thakurta, A. & Parekh, S., 18 Jun 2024, In: Cell Reports Medicine. 5, 6, 101584.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
Thibaud, S., Subaran, R. L., Newman, S., Lagana, A., Melnekoff, D. T., Bodnar, S., Ram, M., Soens, Z., Genthe, W., Brander, T., Mouhieddine, T. H., Van Oekelen, O., Houldsworth, J., Cho, H. J., Richard, S., Richter, J., Rodriguez, C., Rossi, A., Sanchez, L. & Chari, A. & 4 others, , 1 Nov 2024, In: Blood cancer discovery. 5, 6, p. 428-441 14 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma
Dutta, R. P., Thibaud, S., Leshchenko, V., Ram, M., Melnekoff, D. T., Bhalla, S., Restrepo, P., Gupta, V. A., Barwick, B. G., Newman, S., McCafferty, J., Hantash, F., Nooka, A. K., Cho, H. J., Richard, S., Rodriguez, C., Rossi, A., Sanchez, L., Chari, A. & Boise, L. H. & 4 others, , Dec 2024, In: Blood Neoplasia. 1, 4, 100049.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward
Ram, M., Fraser, M. R., Dos Santos, J. V., Tasakis, R., Islam, A., Abo-Donia, J. U., Parekh, S. & Lagana, A., 2024, In: Pharmacogenomics and Personalized Medicine. 17, p. 573-609 37 p.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
The Search for Cancer Drivers
Laganà, A., 2024, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). Springer Science and Business Media Deutschland GmbH, p. 145-171 27 p. (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics); vol. 14070 LNCS).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
2 Scopus citations
Press/Media
-
BIDMC Researchers Help Define Risk in Multiple Myeloma Using Tumor Microenvironment Analysis
Nie, K., Kim-Schulze, S., D'Souza, D., Rahman, A., Laganà, A., Cho, H., Gnjatic, S. & Chen, Z.
9/01/26
2 items of Media coverage
Press/Media
-
BIDMC Researchers Help Define Risk in Multiple Myeloma Using Tumor Microenvironment Analysis
Nie, K., Kim-Schulze, S., D'Souza, D., Rahman, A., Laganà, A., Cho, H., Gnjatic, S. & Chen, Z.
9/01/26
1 item of Media coverage
Press/Media
-
Mount Sinai Showcases Hematology Research at the 67th ASH Annual Meeting
Shih, A., Mouhieddine, T., Papapetrou, E., Parekh, S., Laganà, A., Jagannath, S., Marron, T., Tremblay, D., Brody, J., Ferrara, J., Mascarenhas, J., Wagenblast, E., Curtis, S. & Dutta, R. P.
3/12/25 → 4/12/25
3 items of Media coverage
Press/Media
-
HMN 2025: why some myeloma patients stay cancer-free for years after CAR T therapy
21/11/25
1 item of Media coverage
Press/Media
-
Patient Immune System Characteristics and Long-Term Remission From CAR T-Cell Therapy in Multiple Myeloma
20/11/25
1 item of Media coverage
Press/Media
-
-
Mount Sinai Study Reveals Why Some Myeloma Patients Stay Cancer-Free for Years After CAR T Therapy
12/11/25 → 13/11/25
7 items of Media coverage
Press/Media
-
Mount Sinai Study Uncovers Why Certain Myeloma Patients Remain Cancer-Free Long After CAR T Therapy
12/11/25
2 items of Media coverage
Press/Media
-
Mount Sinai Researchers Pioneer First Targeted Therapy for Rare T-Cell Lymphoma After CAR T Treatment
Merad, M., Mouhieddine, T., Parekh, S., Laganà, A., Brown, B., Jagannath, S., Brody, J., Brunner, P., Baskovich, B., Odak, I., Dutta, R. P. & Melnekoff, D.
21/08/25 → 22/08/25
5 items of Media coverage
Press/Media
-
Spar Nord Bank's Extraordinary Meeting Highlights and Changes
Jensen, A.
24/06/25
1 item of Media coverage
Press/Media
-
Proceedings Of The Extraordinary General Meeting Of Spar Nord Bank A/S
Jensen, A.
24/06/25
1 item of Media coverage
Press/Media